Loading...

Celularity Inc.

GXGXW•NASDAQ
Healthcare
Biotechnology
$1.70
$0.50(41.67%)

Celularity Inc. (GXGXW) Stock Overview

Explore Celularity Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

B

Score: 59.8/100

Key Financials

Market Cap237.7M
P/E Ratio-0.99
EPS (TTM)N/A
ROE-3.35%
Fundamental Analysis

AI Price Forecasts

1 WeekN/A
1 MonthN/A
3 MonthsN/A
1 Year Target$2.88

GXGXW Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Celularity Inc. (GXGXW) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

Our forecasting models predict significant price movements, with a 12-month target of $2.88.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -0.99 and a market capitalization of 237.7M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

Frequently Asked Questions

;